Business
With a reputation as the ‘pharmacy of the world,’ India is geared to mass-produce COVID-19 vaccines – ABC News
India has become a global powerhouse for generic pharmaceutical drugs and the hope is that this could make Indian companies like the Serum Institute, which is the…
While the Pfizer COVID-19 vaccine rollout in the United Kingdom and the United States has been widely heralded as the beginning of the end of the pandemic, much of the developing world has its hopes set elsewhere.
India has become a global powerhouse for generic pharmaceutical drugs and accounts for about 60 per cent of the world’s vaccine supplies, earning a reputation as the “pharmacy of the world”.
And unlike the Pfizer vaccine which is safe and effective but relatively expensive and unstable…
-
General10 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General13 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News12 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business10 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher